Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06207812 · ClinicalTrials.gov registry record
Long-term Outcomes Associated With Juvenile-onset Mycosis Fungoides and Lymphomatoid Papulosis
A clinical trial of Mycosis Fungoides and Lymphomatoid Papulosis, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT06207812: Recruiting study of Mycosis Fungoides and Lymphomatoid Papulosis, sponsored by M.D. Anderson Cancer Center.
NCT06207812 is a study of Mycosis Fungoides and Lymphomatoid Papulosis that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 100 participants, below the 158-participant average among 19 other Mycosis Fungoides trials with a reported enrollment target (37% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06207812, a study of Mycosis Fungoides and Lymphomatoid Papulosis, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
To follow up with all our participants with juvenile-onset mycosis fungoides, check on their status, and ask them or their parents about long term outcomes associated with their condition.
Primary Outcome
Incidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE)
Conditions Studied
Study Locations (1)
Texas
- MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2024-01-19 |
| Est. Completion | 2028-01-12 |
What NCT06207812 shows while recruiting
NCT06207812 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 158-participant average among 19 other Mycosis Fungoides trials with a reported enrollment target (37% lower).
The record links to 2 conditions, with Mycosis Fungoides appearing as the primary indexed condition, and to 0 interventions.
NCT06207812 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT06207812 about?
NCT06207812 is a clinical study titled "Long-term Outcomes Associated With Juvenile-onset Mycosis Fungoides and Lymphomatoid Papulosis". To follow up with all our participants with juvenile-onset mycosis fungoides, check on their status, and ask them or their parents about long term outcomes associated with their condition.
What is the current status of trial NCT06207812?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2024-01-19. Estimated completion is 2028-01-12.
What conditions does trial NCT06207812 study?
This clinical trial studies the following conditions: Mycosis Fungoides, Lymphomatoid Papulosis.
Who is sponsoring clinical trial NCT06207812?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06207812 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Mycosis Fungoides
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06207812's enrollment target sits among peer trials
100 4th of 19 higher than 16 of 19 other Mycosis Fungoides trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Mycosis Fungoides trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Intravenous Vesicular Stomatitis Virus in Patients With Peripheral T-cell Lymphoma
RECRUITING · Phase 1
-
Combining Topical Imiquimod With Local Radiotherapy for Treatment of Mycosis Fungoides
RECRUITING · Early Phase 1
-
Photopheresis in Early-stage Mycosis Fungoides
RECRUITING · Phase 2
-
Mogamulizumab and Brentuximab Vedotin in CTCL and Mycosis Fungoides
RECRUITING · Phase 1
-
ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome
RECRUITING
-
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI